Use of defibrotide to treat adult patients with transplant-associated thrombotic microangiopathy

Saved in:
Bibliographic Details
Published inBone marrow transplantation (Basingstoke) Vol. 54; no. 1; pp. 142 - 145
Main Authors Martínez-Muñoz, M. E., Forés, R., Lario, A., Bautista, G., Bueno, J. L., de Miguel, C., Navarro, B., De Laiglesia, A., Sánchez-Guerrero, A., Cabrera, J. R., Duarte, R. F.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.01.2019
Nature Publishing Group
Subjects
692/700/565/1436
692/700/565/2194
Adolescent
Adult
Adults
Allografts
Cardiovascular diseases
Care and treatment
Cell Biology
Complications and side effects
Correspondence
Development and progression
Drugstores
Female
Fibrinolytic agents
Hematologic Neoplasms - mortality
Hematologic Neoplasms - therapy
Hematology
Hematopoietic Stem Cell Transplantation
Humans
Internal Medicine
Male
Medical research
Medicine
Medicine & Public Health
Middle Aged
Patient outcomes
Pharmacy
Public Health
Stem Cells
Surgery
Thrombotic Microangiopathies - etiology
Thrombotic Microangiopathies - mortality
Thrombotic microangiopathy
Transplantation Conditioning
Transplants
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0268-3369
1476-5365
DOI:10.1038/s41409-018-0256-8